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Experimental studies have demonstrated that the neurotrophin brain-derived neutrophic
factor (BDNF) is required for the appropriate development of the central respiratory
network, a neuronal complex in the brainstem of vital importance to sustaining life.
The pontine Kölliker-Fuse nucleus (KFN) is a fundamental component of this circuitry
with strong implications in the pre- and postnatal breathing control. This study provides
detailed account for the cytoarchitecture, the physiology and the BDNF behavior of the
human KFN in perinatal age. We applied immunohistochemistry in formalin-fixed and
paraffin-embedded brainstem samples (from 45 fetuses and newborns died of both known
and unknown causes), to analyze BDNF, gliosis and apoptosis patterns of manifestation.
The KFN showed clear signs of developmental immaturity, prevalently associated to
BDNF altered expression, in high percentages of sudden intrauterine unexplained death
syndrome (SIUDS) and sudden infant death syndrome (SIDS) victims. Our results indicate
that BDNF pathway dysfunctions can derange the normal KFN development so preventing
the breathing control in the sudden perinatal death. The data presented here are also
relevant to a better understanding of how the BDNF expression in the KFN can be involved
in several human respiratory pathologies such as the Rett’s and the congenital central
hypoventilation syndromes.
Keywords: human brainstem development, Kölliker-Fuse nucleus, BDNF, SIDS, SIUDS, gliosis, apoptosis, maternal
smoking in pregnancy
INTRODUCTION
To accomplish all vital homeostatic functions, a proper res-
piratory rhythmogenesis is crucial at birth. The central ven-
tilatory rhythm is produced and coordinated by a network
of neuronal centers located in the brainstem (Ramirez and
Richter, 1996; Viemari et al., 2003; Wong-Riley and Liu, 2005).
Experimental studies have demonstrated that during prena-
tal development this circuitry undergoes marked maturational
changes which include modifications in the morphological, bio-
chemical and electrophysiological properties of specific neu-
rons of the respiratory components (Ritter and Zhang, 2000;
Feldman et al., 2003; Alheid and McCrimmon, 2008), as well as
enhancement of their synaptic interactions (Paton and Richter,
1995), so that it will be fully developed and operating at
birth.
The pontine Kölliker-Fuse (KF) is a key nucleus in the res-
piratory network for primary breathing, with strong implica-
tions in pre- and postnatal life. During intrauterine life, the KF
inhibits the central and peripheral chemoreceptors (which are
already fully developed and potentially functional), and there-
fore any respiratory reflex. At birth, the KF abruptly reduces its
inhibitory effects and becomes active as a respiratory center that
starts up the ventilatory activity through extensive afferent and
efferent connections with the other respiratory-related structures
(Dutschmann et al., 2004; Ezure, 2004; Dutschmann andHerbert,
2006).
Studies by Erickson et al. (1996) firstly demonstrated that
brain-derived neurotrophic factor (BDNF), a member of the
neurotrophin class of growth factors, is required for the devel-
opment of normal breathing in mice, both for regulating the
maturation of specific neurons in brainstem centers involved in
respiratory control, and for stimulating their connections. Other
authors have since studied this topic (Balkowiec and Katz, 1998;
Katz, 2003; Lu, 2003; Kron et al., 2007a,b; Ogier et al., 2013).
In particular, Kron et al. (2007a,b) showed the specific involve-
ment of BDNF in both fetal GABAergic inhibitory and postnatal
glutamatergic excitatory synaptic transmission in the KF of rats.
This behavior of the BDNF is very likely similar in humans
but the related molecular mechanisms of expression and func-
tions are largely unknown. The present study was undertaken
to specifically test the hypothesis that the KF nucleus is a tar-
get of BDNF signaling to foster a normal breathing pathway. In
particular, we supposed that the BDNF can contribute to the
inhibitory and stimulatory actions on breathing exerted by the
KFN before and after birth, respectively. To approach this issue we
applied BDNF immunohistochemistry to serial histological sec-
tions of brainstem, particularly of the specific specimen where the
KF nucleus (KFN) is located, from subjects who died perinatally
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of both known and unknown causes. The aims of the research
were: firstly to evaluate whether and how the KF neurons dis-
play BDNF immunoreactivity; secondly, to investigate whether
developmental defects of the KFN, that are not uncommon in
sudden perinatal deaths (Lavezzi et al., 2004a,b,c), are associated
with alterations of BDNF expression. The study protocol included
immunohistochemical detection in those same cases of apoptosis,
given the important role of the BDNF also in neuronal survival
and/or programmed death occurring during the development of
the nervous system (Ricart et al., 2006), and of the Glial Fibrillary
Acid Protein (GFAP), a marker of reactive gliosis in neurode-
generative processes (Sofroniew and Vinters, 2010; Robel et al.,
2011).
METHODS
A total of 45 brains were studied, from 27 ante-partum still-
births (25–40 gestational weeks-gw, mean age: 37.5 gw), and 18
infants who survived for periods ranging between 1 h and 6
months (mean age: 3.2 months). All these cases were sent to
the “Lino Rossi” Research Center of Milan University according
to the application of the Italian law n.31/2006 “Regulations for
Diagnostic Post Mortem Investigation in Victims of sudden Infant
Death Syndrome (SIDS) and Unexpected Fetal Death.” This law
decrees that all infants suspected of SIDS who died suddenly in
Italian regions within the first year of age, as well as all fetuses who
died without any apparent cause (SIUDS: Sudden Intrauterine
Unexplained Death Syndrome), must be submitted to a thorough
diagnostic post-mortem investigation.
CONSENT
Parents of all the victims of the study provided written informed
consent to autopsy, and approval was obtained from the Milan
University “Lino Rossi” Research Center institutional review
board.
The victims were subjected to a complete autopsy, including
examination of the placental disk, umbilical cord and membranes
in fetal deaths. In all cases an in-depth histological examination
of the autonomic nervous system was made, according to the
protocol provided by the Law 31 (Matturri et al., 2005, 2008).
Briefly, examination of the brainstem was performed, after fixa-
tion in 10% phosphate-buffered formalin, through the sampling
of three specimens, as shown in Figure 1. The first specimen,
ponto-mesencephalic, includes the upper third of the pons and
the adjacent portion of mesencephalon. The second extends from
the upper medulla oblongata to the adjacent portion of the caudal
pons. The third specimen takes as reference point the medullary
obex, a few mm above and below it.
The three samples were embedded in paraffin and serially cut
at intervals of 30µm. For each level, twelve 5µm sections were
obtained, two of which were routinely stained using alternately
hematoxylin-eosin and Klüver-Barrera stains, while three sections
were treated for immunohistochemical detection of BDNF, apop-
tosis and GFAP, respectively. The remaining sections were saved
for further investigations and stained as deemed necessary.
The routine histological evaluation of the brainstem was per-
formed on the locus coeruleus and the Kölliker-Fuse nucleus (the
focus of this study) in the first specimen; on the parafacial/facial
complex, the superior olivary complex and the retrotrapezoid
nucleus in the second sample, and on the hypoglossus, the dorsal
motor vagal, the ambiguus, the pre-Bötzinger, the inferior oli-
vary, the arcuate nuclei and the solitary tract complex in the third
medullary sample.
In 29/45 cases, after the in-depth autoptic examination, the
death remained totally unexplained. A diagnosis of “SIUDS” was
FIGURE 1 | Schematic representation of the brainstem sampling. On the
left: ventral surface; on the right: dorsal surface. I, ponto-mesencephalic
specimen, including the upper third of the pons and the adjacent portion of
mesencephalon; II, medullar-pontine specimen, extending from the upper
medulla oblongata to the adjacent portion of the caudal pons; III, medulla
oblongata specimen, including the obex. Figures are from the “Online
Neuroscience Resource”- available at the website: http://www.
neuroanatomy.wisc.edu/virtualbrain/BrainStem/24PAG.html.
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made for 19 fetuses who died suddenly after the 25th gestational
week, and a diagnosis of “SIDS” for 10 infants who died within the
first 6 months of life. In the remaining 16 cases, 8 stillbirths, and 8
infants, a precise cause of death was formulated at autopsy. These
cases were regarded as “controls.” Table 1 summarizes the sub-
jects analyzed in this study, indicating the sex distribution, range
of ages and death diagnoses.
For each case, a complete clinical history, with particular ref-
erence to maternal lifestyle (including cigarette smoking, alcohol
and drug abuse), was collected. None of the mothers had any
significant pathology. Thirteen of the 29 SIUDS/SIDS mothers
(45%) were active smokers before and during the pregnancy,
smoking >3 cigarettes/day. The remaining 16 mothers (55%)
reported no history of cigarette smoking. Three mothers of vic-
tims in the control group (19%) had a smoking habit, while 13
mothers (81%) were non-smokers.
Immunohistochemical techniques
BDNF detection. Sections from paraffin-embedded tissue blocks
were stained using commercially supplied rabbit monoclonal
antibodies against the brain-derived neurotrophic factor, also
known as BDNF [abcam (EPR1292), ab108319]. Slides were
boiled for the antigen retrieval in EDTA buffer, using a microwave
oven, at 600W for 3 times at 5min each, and finally cooled.
The antibody was diluted 1:140 in PBS. A standard ABC tech-
nique avidin-biotin complex (Vectastain elite ABC KIT, PK-6101)
was used with HRP-DAB to visualize and develop the antigen-
antibody reaction. All the slides selected for this study were sub-
mitted at the same time to the immunohistochemical procedures,
with particular attention to the simultaneous incubation in the
DAB-peroxidase solution to avoid differences in the immunos-
taining. Sections were counterstained with Mayer’s hematoxylin,
than coverslipped.
A set of sections from each group of the study was used as neg-
ative control. Precisely, the tissue samples were stained using the
same procedure but omitting the primary antibody in order to
Table 1 | Case profiles of the study.
Victims Age Sex Death diagnosis
(range)
M F Explained death Unexplained
death
Controls
(n.16) (n.29)
Fetuses
(n.27)
25–40 gw 12 15 Necrotizing
chorioamnionitis (n.5)
Congenital heart
disease (n.3)
SIUDS (n.19)
Newborns
(n.18)
1 h–6m 10 8 Congenital heart
disease (n.5)
Pneumonia (n.2)
Pericarditis (n.1)
SIDS (n.10)
gw, gestational week; h, hour; m, month; SIDS, Sudden Infant Death Syndrome;
SIUDS, Sudden Intrauterine Unexplained Death Syndrome.
verify that the immunolabeling was not due to nonspecific label-
ing by the secondary antibody. In fact, if specific staining occurs
in negative control tissues, immunohistochemical results should
be considered invalid.
Quantification of BDNF immunohistochemical expression. The
degree of positive immunoreactivity in the brainstem histolog-
ical sections was defined for every case by two independent
and blinded observers as the number of neurons with unequiv-
ocal brown immunostaining, divided by the total number of
cells counted in the same area, expressed as percentage (BDNF
immunopositivity index: BDNF-Index). BDNF-Index was classi-
fied as: “Class 0” for absolutely no staining (negativity); “Class 1”
when the index of strong immunopositive neurons was < 10%
or even >10% but only of slightly immunopositive cells (weak
positivity); “Class 2” with a percentage of intense immunoposi-
tive neurons between 10 and 30% (moderate positivity); “Class
3” with a percentage of intensely brown neurons >30% of the
counted cells (strong positivity).
All slides were evaluated using a Nikon E600 microscope
with Axioplan objectives and identical ND (Neutral Density)
filters. Images were acquired at different magnification using a
Microlumina Ultra Resolution Scanning Digital Camera.
Apoptosis detection. To detect cells undergoing apoptosis, we
used the technique of Terminal-Transferase dUTPNick End label-
ing technique (TUNEL Apoptag plus peroxidase in situ Apoptosis
detection kit, S7101, Chemicon). This identifies early nuclear
DNA fragmentation by specific binding of terminal deoxynu-
cleotidyl transferase (TdT) to 3′-OH ends of DNA. Sections were
pretreated with proteinase k (20µg/ml) for 15min. Endogenous
hydrogen peroxidase activity was quenched in 3% hydrogen per-
oxide. After a series of rinsing, nucleotides labeled with digoxi-
genin were enzymatically added to the DNA by TdT. The incu-
bation was carried out for 60min the labeled DNA was detected
using anti-digoxigenin-peroxidase for 30min. The chromogen
diaminobenzidine tetra hydrochloride (DAB) resulted in a brown
reaction product. Incubation without TdT served as the negative
control.
GFAP detection. To reveal the reactive astrocytes, sections were
deparaffinized and washed in PBS. After blocking endogenous
peroxidase with 3% H2O2, the slides were pretreated in a
microwave-oven using a citrate solution (pH 6). Then the sections
were incubated overnight with primary monoclonal antibody
NCL-GFAP-GA5 (anti GFAP, Novocastra, Newcastle Tyne, United
Kingdom) at a dilution of 1:300. Immunohistochemical staining
was performed with the peroxidase-antiperoxidase method and
the avidin-biotin complex technique (ABC Kit, Vectastain, Vector
Laboratories Inc., Burlingame, CA, U.S.A.). Diaminobenzidine
(DAB, Vector Laboratories Inc., Burlingame, CA, U.S.A.) was
used as chromogen substrate and counterstained with light hema-
toxylin. Negative controls of the same tissue were done using PBS
instead of primary antibody.
GABA (γ-aminobutyric acid) detection. Immunohistochemistry
to identify interneurons, typically inhibitory cells that use the
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neurotransmitter GABA, was performed by anti-parvalbumin
mouse monoclonal IgG antibody (Millipore Chemicon
International cat. MAB1572). Sections, after deparaffinizing
and rehydrating, were immersed and boiled in a citrate solution
pH 6.0 for the antigen retrival with a microwave oven, having
first blocked endogenous peroxidase by 3% hydrogen peroxide
treatment. Then sections were incubated with the primary
antibody overnight (1:1000 dilution) in a wet chamber. Samples
were washed with a PBS buffer and processed with a usual avidin-
biotin-immunoperoxidase technique and finally counter-stained
with Mayer’s Hematoxylin and coverslipped. Negative controls
were prepared omitting the primary antibody and replacing only
with PBS.
Statistical analysis
The statistical significance of direct comparisons between the
groups of victims was determined using analysis of variance
(ANOVA). Statistical calculations were carried out with SPSS sta-
tistical software. The differences were statistically significant if
p-value was<0.05.
RESULTS
MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL EXAMINATION OF
THE KFN
Control group
Morphology. We firstly examined the KFN in serial histologi-
cal sections from the first brainstem sample (Figure 1) of all
16 subjects who died of known causes, with the aim of delin-
eating the normal features of this nucleus in human perinatal
life. This examination reaffirmed in more detail our previous
reports on this topic (Lavezzi et al., 2004a,b), establishing that
the KFN, already well developed at 25 gestational weeks, extends
longitudinally from the rostral pons to the lower portion of the
mesencephalon, up to the level just where the caudal pole of
the red nucleus appears. Its cytoarchitecture is well visible in
the more cranial transverse sections of the pons, namely those
bordering the caudal mesencephalon, identifiable by the pres-
ence of the superior cerebellar peduncle decussation. Figure 2
represents a transverse cranial section of rostral pons show-
ing the location of the KFN. The KFN appears as a group
of large neurons, located between the peduncle crossing and
the medial lemniscus. These neurons show a distinct, eccen-
tric nucleus with an evident nucleolus, and abundant cyto-
plasm with Nissl substance located at the cell periphery. On
the basis of the neuronal arrangement, it is possible to define
two KF subnuclei: the “compactus subnucleus,” consisting of
a cluster of a few large neurons, and the adjacent “dissipa-
tus subnucleus” with scattered neurons. Intermixed with these
large neurons, smaller cells (interneurons and astrocytes) are
visible (Figure 3). Interneurons in particular, in contrast to the
typical morphological features of the large KF neurons, had,
beyond the lower cell body size, wrinkled nuclei, indistinct
nucleoli, inconspicuous Nissl bodies and small extension of
the dendritic arbor. In addition, their presence has been con-
firmed by the specific immonohistochemical method using the
anti-parvalbumin antibody as marker for inhibitory GABAergic
interneurons.
BDNF immunohistochemistry. A noteworthy observation was
that the KF neurons display BDNF immunoreactivity prevalently
in fetal life (Figure 4). An intense expression with dark brown
staining in the cytoplasm of neurons (“Class 3” of BDNF-Index)
was seen in all the 8 fetuses and in 1 newborn, who died in
the first hours of life. Only in a 3 month-old victim a weak
FIGURE 2 | On the left side the ventral brainstem surface scheme with
the indication of the level of the histological section in the rostral pons,
visible to the right. Circles show the bilateral localization of the Kölliker-Fuse
nucleus. Klüver Barrera staining. ml, medial lemniscus; scp, superior
cerebellar peduncle; scpd, decussation of the superior cerebellar peduncles;
4V, fourth ventricle.
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FIGURE 3 | The Kölliker-Fuse nucleus in a histological section of rostral
pons of a control newborn (3 month-old). The boxed area in (A) is
represented at higher magnification in (B). At this magnification it’s possible
to recognize the large Kölliker-Fuse neurons with distinct nucleus and evident
nucleolus (arrows indicate some of these neurons), intermixed to smaller
cells (interneurons and astrocytes). The large neurons can be subdivided in
two groups: a compact subnucleus and a dissipatus subnucleus. Klüver
Barrera staining. Scale bar = 10µm. csn, compact subnucleus; dsn,
dissipatus subnucleus; ml, medial lemniscus; scpd, decussation of the
superior cerebellar peduncles.
FIGURE 4 | BDNF immunopositivity of several neurons of the
Kölliker-Fuse nucleus in a fetus of the control group (34 gestational
weeks). BDNF immunostaining. Scale bar = 10µm.
immunopositivity (“Class 1” of BDNF-Index) of the KF neurons
was observed.
Apoptosis immunohistochemistry. Significant apoptosis, after
application of the TUNEL method, was absent in the KFN of the
fetal control group. Programmed cell death was, instead, confined
to several interneurons in the KF area in 7 of the 8 control infants
(Figure 5).
GFAP immunohistochemistry. Rare astrocytes not expressing
detectable levels of GFAP with none sign of immunopositive reac-
tive astrogliosis were found in the KFN area of all the control
cases.
SIUDS/SIDS group
Morphology. In 14 subjects who died suddenly (7 SIUDS and
7 SIDS), the KF structure did not differ from those of age-
matched controls. However, a decreased number of KF neurons
FIGURE 5 | Apoptotic interneurons in the Kölliker-Fuse nucleus in a
newborn of the control group (2 month-old). Full arrows indicate
immunopositive interneurons; empty arrows indicate some of the
immunonegative large neurons. TUNEL metod immunostaining. Scale
bar = 10µm.
(hypoplasia) was observed in 9 late fetal deaths aged from 38 to 40
gestational weeks and in 3 newborns who died within the first day
of life (Figure 6). In 3 stillbirths (28–32 gestational week-olds),
the KFN was not detectable, unlike to the age-matched control
fetuses in which the KF is already well-developed, thus allowing a
diagnosis of “agenesis” of this nucleus.
BDNF immunohistochemistry. Results consistent with the con-
trol group observations were found in 17 cases (positive BDNF
immunoexpression in 10 SIUDS and negative immunoexpres-
sion in 7 SIDS). An irregular BDNF expression was observed in
the remaining 12 cases: negativity (Class 0 of BDNF-Index) was
found in the three fetuses with KFN agenesis and in 4 sudden
deaths with hypoplasia; very weak to moderate immunopositivity
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FIGURE 6 | Hypoplasia of the Kölliker-Fuse nucleus in a SIUDS case (39
gestational weeks). The boxed area in (A) is represented at higher
magnification in (B). At this magnification only rare suffering Kölliker-Fuse
neurons are visible (see arrows). Klüver Barrera staining. Scale bar =
10µm. ml, medial lemniscus; scpd, decussation of the superior cerebellar
peduncles.
FIGURE 7 | BDNF weak immunopositivity of the Kölliker-Fuse nucleus
in a SIUDS case (35 gestational weeks). Arrows indicate the large
Kölliker-Fuse neurons. BDNF immunostaining. Scale bar = 10µm.
(“Class 1” and “Class 2” of BDNF-Index), only distributed at the
cell periphery, was highlighted in 2 SIUDS cases (Figure 7) and
in 3 newborns died in the first hours of life with KFN hypoplasia.
Collectively, a significantly greater proportion of BDNF signal-
ing dysfunctions were observed in SIUDS/SIDS victims compared
with controls (41 vs. 12%, p < 0.05).
Apoptosis immunohistochemistry. Contrary to what was
observed in controls, positive TUNEL staining was detected in
the KF interneurons of 8 SIUDS cases, and negative apoptotic
signals in 4 SIDS. Frequently these results were associated to
negative/weak BDNF expression and KFN hypoplasia.
GFAP Immunohistochemistry. Numerous reactive astrocytes,
characterized by high-level expression of GFAP immunoreactiv-
ity in spongiform hypertrophic cell bodies and striking increase
in the number, length and thickness of GFAP-positive processes,
were found nearby the large neurons of the KFN in about 40%
FIGURE 8 | Reactive astrocytes (see full arrows) in the Kölliker-Fuse
area in a SIDS case (2 month-old). These cells are characterized by
high-level expression of GFAP immunoreactivity in both hypertrophic cell
bodies and processes that appear striking increased in number, length and
thickness. Empty arrows indicate some of the large GFAP-immunonegative
large neurons of the Kölliker-Fuse nucleus. GFAP immunohistaining. Scale
bar = 10µm.
of both SIUDS and SIDS victims (8/19 and 4/10, respectively)
(Figure 8).
In Table 2, all the results related to the KFN are reported.
Overall, we found one or more combinations of KFN pathologi-
cal findings (i.e., hypoplasia, gliosis, irregular manifestation of the
BDNF and apoptosis) in 19 victims of sudden death (14 SIUDS
and 5 SIDS) and only in 1 control group case. Thus, a significantly
greater proportion of neurological alterations of the KFN was
observed in victims of sudden death as compared with controls
(p < 0.01).
OTHER BRAINSTEM PATHOLOGICAL RESULTS
A subset of SIUDS (11/19) cases showed hypoplasia of the arcu-
ate and the pre-Bötzinger nuclei in the medulla oblongata, and
Frontiers in Human Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 648 | 6
Lavezzi et al. BDNF in Kölliker-Fuse nucleus
Table 2 | Morphological and immunohistochemical findings related to KFN in SIUDS/SIDS and Controls.
Victims Morphology BDNF immunohistochemistry TUNEL method GFAP method
Index:
Normal Hypoplasia Agenesis Positive Negative Positive Negative
Class 3 Class 1/2 Class 0
Strong Weak/ Negative
Moderate
CONTROLS
Fetuses (n.8) 8 – – 8 – – – 8 – 8
Infants (n.8) 8 – – 1a 1 6 7b 1 – 8
SUDDEN DEATH
SIUDS (n.19) 7 9 3 8 2(1c)* 7c** 8b** – 8** 11
SIDS (n.10) 7 3a – – 3a,c 7 6b 4 4 6
SIDS, Sudden Infant Death Syndrome; SIUDS, Sudden Intrauterine Unexplained Death Syndrome.
aDied in the first hours of life.
bConfined to interneurons.
cWith KFN hypodevelopment.
Statistically significant differences SIUDS and SIDS vs. corresponding controls (fetuses and newborns, respectively): *p < 0.05; **p < 0.01.
of the facial parafacial complex in the caudal pons. In 4 cases
these alterations were concomitant with KFN hypoplasia. In the
SIDS group the most frequent alteration was hypoplasia of the
arcuate nucleus (6/10). Also in 25% of the control cases (4/16),
both fetal and infant deaths, hypoplasia of the arcuate nucleus was
detected.
In the majority of cases (both control and SIUDS/SIDS
groups), regardless of the expression pattern in the KFN, the
BDNF was also densely expressed in the ventrolateral subnucleus
of the solitary tract complex, in the pre-Bötzinger nucleus in
the medulla oblongata, and in the retrotrapezoid nucleus in the
caudal pons.
CORRELATION OF KFN FINDINGS WITH SMOKE EXPOSURE
On the whole, the morphological and immunohistochemical
alterations of the KFN resulted significantly related to maternal
smoking (p < 0.01). In fact, in 10 of the 13 victims of sudden
death with a smoker mother (77%) one or more developmental
defects of the KFN were present. Similarly, in the control group,
2 of the 3 newborns (67%) showing anomalous BDNF positive
immunoexpression, had a smoking mother, confirming the role
of smoke absorption in the neuropathogenetic manifestation of
this growth factor.
DISCUSSION
From the experimental reports in literature there is clear evidence
that the neurotrophin BDNF is important for the maturation of
the respiratory network during the prenatal period and for the
primary generation of the respiratory rhythm at birth. In addi-
tion, BDNF has an important role in the stabilization of central
breathing that occurs after birth (Balkowiec and Katz, 1998; Katz,
2003; Lu, 2003; Ogier et al., 2013).
In this study we examined the expression of BDNF in humans,
mainly in the KFN, an essential component of the respiratory
network with important implications before and after birth.
Our research was performed on a wide set of fetuses and
newborns who died of both known (controls) and unknown
causes (SIUDS/SIDS).
Only limited data are available at this moment regarding the
localization and the cytoarchitecture of the human KFN. In this
study we have shown, validating our previous reports (Lavezzi
et al., 2004a,c), that the KFN is well analyzable in histological sec-
tions from the dorsolateral area of the cranial pons, ventral to the
superior cerebellar peduncle decussation, Our data are supported
by the study of Pattinson et al. (2009). These authors, through
combined functional and structural magnetic resonance imaging
techniques applied to brainstem of human volunteers, observed,
after chemical stimulation of breathing, an intense activation in a
brain area of the rostral dorsal pons corresponding to the KFN
localization highlighted by us. In the selected histological sec-
tions of control cases we first defined the cytoarchitecture of this
nucleus, consisting of a small population of large neurons inter-
mixed with smaller interneurons and glial cells. Then, we found
developmental changes in the cytoarchitectural organization and
in the immunoexpression of BDNF in the KFN, particularly in
sudden fetal deaths (SIUDS). This was illustrated in particular
by the prevalent negativity of BDNF signals, unlike the intense
expression found in age-matched fetal controls, that coincides
with the peculiar BDNF function as breathing-inhibitor shown
in experimental studies in prenatal life (Kron et al., 2007b). The
disappearance of positivity observed after birth, above all in con-
trol cases, has been interpreted, on the contrary, as a necessary
step to allow for breathing to start. The BDNF immunopositivity,
even if weak, observed in the KFN of several SIDS cases can there-
fore indicate a continuation of the prenatal inhibitory activity
after birth, leading to severe respiratory deficits and consequently
death.
A remarkable observation was that BDNF deficiency in the
KF neurons of SIUDS and its expression in SIDS victims were
frequently associated with a delayed morphological maturation
of this nucleus (KFN hypoplasia), thus demonstrating that alter-
ations of BDNF expression can derange the KF maturation.
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Therefore, the data obtained from this study essentially indi-
cate that: (1) BDNF has direct effects on breathing inhibition
in fetal life; (2) BDNF is required for normal KFN development
in intrauterine life but is not involved in starting the breathing
and the modulation promoted by the KFN after delivery. Indeed,
BDNF expression in newborns seems to hinder the ventilatory
activity.
Our considerations are, in general, in agreement with the
report by Tang et al. (2012), providing evidence of an abnormal
expression of BDNF in respiratory-related brainstem structures
(although the KFN was not included in their observations) in
SIDS as compared to non-SIDS infants.
The results highlighted by the application of TUNEL immuno-
histochemistry are also interesting. We observed, in fact, the
presence of apoptotic interneurons in the KFN of newborns,
mainly of the control group.
Interneurons are typically small cells distributed in the cen-
tral nervous system (CNS), that form short-distance connections
with neighboring large neurons through the use of the neuro-
transmitter GABA to provide a synaptic inhibitory control (Sato
et al., 2014). During gestation the activity of the respiratory mus-
cles is disabled by the growing number of inhibitory interneurons,
densely distributed above all in the KFN area. At physiologi-
cal delivery, these interneurons are generally stressed, consuming
plenty of oxygen and glucose (Funk et al., 2008). They are then
eliminated by apoptosis, as we have tested in the KFN of control
subjects, thus allowing the breathing to start (Morpurgo et al.,
2004). The high percentage of SIDS cases without apoptotic sig-
nals in the KFN observed in this study could be attributable to
the persistence, after birth, of active interneurons that preserve
their inhibitory effect on the ventilation, thus leading to a fatal
conclusion.
The reactive GFAP-immunopositive astrocytes we found
around the KF neurons in SIUDS/SIDS victims should also be
underlined. Astrocytes are the major glial cell population within
the CNS. They play important physiological roles in brain func-
tions through the release of several neurotrophic factors that
represent the primary event in the maintenance of CNS home-
ostasis, providing support and protection to neurons (Hughes
et al., 2010; Jones and Bouvier, 2014). In addition, astrocytes have
the ability to rapidly react to various noxious neuronal insults,
leading to vigorous astrogliosis (Gourine et al., 2010; Robel et al.,
2011). Subsequently, after severe activation, astrocytes secrete
neurotoxic substances and express an enhanced level of glial fib-
rillary acidic protein (GFAP), which is mostly considered to be
a marker of hypoxic states (Chekhonin et al., 2003). Hypoxia
induces the proliferation of activated astrocytes particularly in
specific brain regions that play an important role in the physiolog-
ical control of breathing, such as the KFN (Becker and Takashima,
1985; Norenberg, 1994).
In our study an important risk factor responsible for hypoxic
conditions has been identified in cigarette smoke, given the high
incidence of smoker mothers. In cases of cigarette smoke absorp-
tion in pregnancy, nicotine and carbon monoxide easily cross the
placental barrier and bind to the fetal hemoglobin. The resulting
carboxyhemoglobin is not able to release oxygen, consequently
inducing alterations of the physiological development of those
organs and tissues most susceptible to hypoxic damage, includ-
ing the brain (Lichtensteiger et al., 1988; Levin and Slotkin, 1998;
Gressens et al., 2003). Besides, nicotine is one of the few lipid-
soluble substances that can cross the blood-brain barrier and act
directly by inducing specific molecular alterations in DNA, RNA,
and proteins of the nervous cells (Gospe et al., 1996).
Smoking may also be responsible for aberrant BDNF behav-
iors. In fact, we frequently observed an altered expression of
BDNF in SIUDS/SIDS subjects with smoker mothers. In sup-
port of this hypothesis is the demonstration that a multitude of
stimuli, including nicotine absorption, alter BDNF gene expres-
sion, by modifying BDNF mRNA in specific neuronal structures
(Lindholm et al., 1994).
It is important to point out several limitations of this study.
Firstly, the relatively small number of cases of SIUDS and particu-
larly of SIDS and controls, that allows us to formulate hypotheses
but not gain confirmation. Secondly, failure to make a specific
examination of the tropomyosin-related kinase B (TrkB) recep-
tor, a protein with high affinity toward several neurotrophins, that
interacts in particular with BDNF to mediate neuronal growth
during CNS development (Soppet et al., 1991; Aoki et al., 2000;
Tang et al., 2010). Such research is now in progress in our
Research Center, however, as we are planning to examine the
behavior of this specific receptor in a wider set of perinatal deaths.
In conclusion, we can state that BDNF appears to be required
for the development of the KFN in human fetal life and for its
inhibitory function on the central respiratory output occurring
in utero. Interestingly, the BDNF role in the breathing mecha-
nism is different in fetal and neonatal life. In fact, in contrast
with the indispensable high BDNF expression in KF neurons in
utero, its manifestation in newborns results associated to severe
impairment of the respiratory activity.
In any case, the altered behavior of the BDNF system observed
in SIUDS/SIDS victims may hinder the KFN function, com-
promising the respiratory control in both fetal and postnatal
life.
Our findings differ from the reports in literature related to
experimental studies, showing BDNF signaling in KF neurons
also after birth. It should be noted, however, that this differ-
ent behavior in man only affects the KFN. In fact, BDNF was
expressed in other respiratory structures (in particular the soli-
tary tract complex, the pre-Bötzinger and the retrotrapezoid
nuclei) in all stages of life. These observations emphasize the
need to intensify the studies on BDNF expression in the human
brainstem.
Finally, we point out that BDNF, as a neuromodulator in
human KF, may have a physiological importance and clinical rel-
evance in a wide range of human developmental disorders of the
breathing. A dysregulation of BDNF expression has been linked
with Rett’s syndrome (RTT), for example, a childhood neurolog-
ical disease associated with a mutation in the gene MeCP2 and
serious impairment of the ventilatory activity (Rett, 1986; Katz
et al., 2009). Mironov et al. (2009) demonstrated, in a mouse
model of RTT, that BDNF deficits are most prominent in neu-
ronal structures of the brainstem deputed to autonomic and
respiratory control. Importantly, Wang et al. (2006) revealed, in
MeCP2 null mice, significant decreased levels of BDNF expression
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in the nucleus of the solitary tract, a nucleus proposed as source
for BDNF release in the KFN.
In the idiopathic congenital central hypoventilation syndrome
(CCHS), a rare disorder characterized by an abnormal control of
respiration despite the absence of neuromuscular or lung disease
or an identifiable brainstem lesion (Weese-Mayer et al., 1992),
several authors have shown an important contribution of BDNF
system dysfunction to the pathophysiological mechanism leading
to this specific respiratory deficiency. Chiaretti et al. (2005), in
particular, found a reduction of BDNF in the cerebrospinal fluid
of patients affected by Ondine’s curse compared with the mean
level in the control group. Weese-Mayer (Weese-Mayer et al.,
2002) highlighted a mutation of the BDNF gene, although not
very frequent, in children with CCHS, supporting the relevance
of this identified mutation in the respiratory control.
A further interesting point to verify will be whether the link
between BDNF deregulations and breathing activity perturba-
tions highlighted in these pathologies originates from an impaired
synaptic transmission and developmental alterations of the KFN.
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